Management of Sexually Transmitted Diseases in HIV-Infected Men and Women
Supporting Assets
Table 1 | Table 2 | Table 3 | Table 4 | Table 5
Table 1. Recommendations for Routine STD Screening in the HIV-Infected Patient
First Visit
|
Subsequent Routine Visits:
|
CLIA, chemoluminescent immunoassay; EIA, enzyme immunoassay; NAAT, nucleic acid amplification test; RPR, rapid plasma reagin test; VDRL, Venereal Diseases Research Laboratory test.
*See Table 3 for alternative approaches for syphilis testing.
†Cell culture for Neisseria gonorrhoeae and Chlamydia trachomatis are the only tests currently approved by the US Food and Drug Administration for use at rectal and pharyngeal sites. Many health departments and commercial laboratories have performed their own validation of NAAT for this purpose. Consult local STD program authorities or see http://www.cdc.gov/std/general/dcl-ng-ct-testing-7-13-2009.pdf for more information.
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Sexually Transmitted Diseases